Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 849-857

  Simpson, Melanie A ^a   Wilson, Christopher M ^a   McCarthy, James B ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; HYALURONIC ACID; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0036731865     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64245-9     Document Type: Article

References (46)

1. Cancer statistics, 1999
2. Hyaluronan: Its nature, distribution, functions and turnover
3. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells
4. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme
5. Hyaluronan is a prerequisite for ductal branching morphogenesis
6. Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothetial cells in vitro
7. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival
8. Hyaluronan expression in differentiated thyroid carcinoma
9. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer
10. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer
11. Tumor-associated hyaluronic acid: A new sensitive and specific urine marker for bladder cancer
12. The glycosaminoglycans of normal and hyperplastic prostate
13. Glycosaminoglycans of human prostatic cancer
14. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
15. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer
16. Hyaluronan synthases
17. Functional cloning of the cDNA for a human hyaluronan synthase
18. Molecular identification of a putative human hyaluronan synthase
19. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family
20. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44
21. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
22. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity
23. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells
24. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice
25. Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells
26. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells
27. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: Effects of VEGF-toxin conjugate on tumor microvessel density
28. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity
29. Hyaturonic acid-like substance from mouse ovaries with angiogenic activity
30. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin
31. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration
32. Inhibiting the differentiation of myocardiocytes by hyaluronic acid
33. Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein
34. Hyaluronan production increases the malignant properties of mesothelioma cells
35. Hyaluronan reduces migration and proliferation in CHO cells
36. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells
37. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function
38. Expression of human hyaluronan synthases in response to external stimuli
39. Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: A molecular mechanism contributing to organ atrophy
40. In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack
41. Group A Streptococcus tissue invasion by CD44-mediated cell signalling
42. Angiogenesis induced by degradation products of hyaluronic acid
43. Tumour-associated hyaluronan: A potential regulator of tumour angiogenesis
44. The role of hyaluronan in tumour neovascularization
45. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo
46. Signaling properties of hyaluronan receptors